FR2835254B1 - Derives de thiazoles dans le traitement de maladies neurologiques - Google Patents

Derives de thiazoles dans le traitement de maladies neurologiques

Info

Publication number
FR2835254B1
FR2835254B1 FR0200905A FR0200905A FR2835254B1 FR 2835254 B1 FR2835254 B1 FR 2835254B1 FR 0200905 A FR0200905 A FR 0200905A FR 0200905 A FR0200905 A FR 0200905A FR 2835254 B1 FR2835254 B1 FR 2835254B1
Authority
FR
France
Prior art keywords
treatment
neurological diseases
thiazole derivatives
thiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200905A
Other languages
English (en)
French (fr)
Other versions
FR2835254A1 (fr
Inventor
Jeremiah Harnett
Christine Dolo
De Lassauniere Pierre Chabrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR0200905A priority Critical patent/FR2835254B1/fr
Priority to PCT/FR2003/000228 priority patent/WO2003062232A1/fr
Priority to ARP030100208A priority patent/AR038219A1/es
Publication of FR2835254A1 publication Critical patent/FR2835254A1/fr
Application granted granted Critical
Publication of FR2835254B1 publication Critical patent/FR2835254B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0200905A 2002-01-25 2002-01-25 Derives de thiazoles dans le traitement de maladies neurologiques Expired - Fee Related FR2835254B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0200905A FR2835254B1 (fr) 2002-01-25 2002-01-25 Derives de thiazoles dans le traitement de maladies neurologiques
PCT/FR2003/000228 WO2003062232A1 (fr) 2002-01-25 2003-01-24 Derives de thiazoles utiles dans le traitement de maladies neurologiques
ARP030100208A AR038219A1 (es) 2002-01-25 2003-01-24 Derivados de tiazol que se utilizan en el tratamiento de enfermedades neurologicas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200905A FR2835254B1 (fr) 2002-01-25 2002-01-25 Derives de thiazoles dans le traitement de maladies neurologiques

Publications (2)

Publication Number Publication Date
FR2835254A1 FR2835254A1 (fr) 2003-08-01
FR2835254B1 true FR2835254B1 (fr) 2006-04-07

Family

ID=27589580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200905A Expired - Fee Related FR2835254B1 (fr) 2002-01-25 2002-01-25 Derives de thiazoles dans le traitement de maladies neurologiques

Country Status (3)

Country Link
AR (1) AR038219A1 (es)
FR (1) FR2835254B1 (es)
WO (1) WO2003062232A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2272911T3 (es) * 2003-04-25 2007-05-01 Neurofit Sas Uso de derivados de fenotiazina piperazina en la fabricacion de un medicamento con efectos neuroprotector y/o neurotroficos sobre cns y/o pns.
EP1945635B1 (en) * 2005-08-18 2009-05-06 F.Hoffmann-La Roche Ag Thiazolyl piperidine derivatives useful as h3 receptor modulators
GB0614365D0 (en) * 2006-07-19 2006-08-30 Proaxon Ltd Pharmaceutical compositions and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
DE69132944T2 (de) * 1990-11-30 2002-11-21 Otsuka Pharmaceutical Co., Ltd. Azolederivate als Inhibitor von Superoxide-Radikalen
HUP0202249A3 (en) * 1999-07-09 2003-01-28 Ortho Mcneil Pharm Inc Neurotrophic pyrrolidines and piperidines, compositions containing them and use of the compounds
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof

Also Published As

Publication number Publication date
AR038219A1 (es) 2005-01-05
FR2835254A1 (fr) 2003-08-01
WO2003062232A1 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60329123D1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DE60325209D1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
DE60138146D1 (de) Frühdiagnose von konformationellen Erkrankungen
IS7623A (is) Sískammtalausnar töflusamsetning úr pramipexóli
FI20060154A (fi) Neurogeneratiivisten tilojen hoito
DE60216275D1 (de) Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit
HK1083062A1 (en) Treatment of diseases and conditions mediated by increased phosphorylation
EP1487446A4 (en) BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES
AU2003268531A8 (en) Materials and methods for treatment of allergic diseases
IS6918A (is) Meðferð erfiðra æxla með notkun epóþílon afleiða
IL163752A0 (en) Use of epothilones in the treatment of brain diseases associated with proliferative processes
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20044250L (no) Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
GB0321384D0 (en) Pteridine derivatives for the treatment of septic shock and TNF-alpha- related diseases
FR2835254B1 (fr) Derives de thiazoles dans le traitement de maladies neurologiques
DE602004014138D1 (de) Benzothiazole derivate und ihre anwendung in der behandlung von adenosine a2a rezeptor vermittelte krankheiten

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20100930